Related Experiment Video
Updated: Jun 1, 2026

Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons
Published on: October 10, 2025
Trabectedin-related rhabdomyolysis: an uncommon but fatal toxicity
Aikaterini Stoyianni1, Nikolaos Kapodistrias, Eleutherios Kampletsas
1Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece.
Abstract:
Rhabdomyolysis is defined as the dissolution of striped muscle characterized by the leakage of intracellular muscle components into the circulation, which can ultimately lead to renal failure with a possible fatal outcome. Trabectedin is a potential cause of rhabdomyolysis. Herein, we describe a case of rhabdomyolysis in a female patient with recurrent metastatic leiomyosarcoma of the uterus and who had full recovery, and we review the already published cases in order to identify a common pattern of emergence.
Insights
Trabectedin can cause rhabdomyolysis, a serious muscle condition. This case study details a patient with uterine leiomyosarcoma who recovered fully from drug-induced rhabdomyolysis.
Area of Science:
- Oncology
- Pharmacology
- Nephrology
Background:
- Rhabdomyolysis is a critical condition involving muscle breakdown and potential kidney failure.
- Trabectedin is an established chemotherapy agent used for soft tissue sarcomas.
- Uterine leiomyosarcoma is a rare malignancy requiring effective treatment options.
Observation:
- A patient with recurrent metastatic uterine leiomyosarcoma developed rhabdomyolysis.
- The patient received Trabectedin as part of her treatment regimen.
- The rhabdomyolysis resolved completely following medical intervention.
Findings:
- This case highlights Trabectedin as a potential iatrogenic cause of rhabdomyolysis.
- A review of existing literature was conducted to identify patterns of Trabectedin-induced rhabdomyolysis.
- Early recognition and management are crucial for favorable outcomes.
Implications:
- Clinicians should maintain a high index of suspicion for rhabdomyolysis in patients treated with Trabectedin.
- Understanding the emergence patterns may aid in predicting and preventing this adverse event.
- This case contributes to the understanding of Trabectedin's safety profile in gynecologic oncology.
Related Concept Videos
Drug Toxicity: Overview
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Risk factors
Drug Toxicity: Dose-Dependent Reactions
Physical Properties of Amines
Rocky Mountain Spotted Fever